TTR and vitreous hemorrhage: Although 15 TTR mutations are nonamyloidogenic, other TTR mutations induce systemic amyloidosis, which can be classified into several phenotypes including peripheral neuropathy dominant type, commonly called FAP; cardiomyopathy dominant type, also known as familial amyloidotic cardiomyopathy; vitreous opacity dominant type, which is thought to be derived mainly from TTR synthesized from RPE cells; and leptomeningeal amyloidosis dominant type, which is believed to be derived mainly from the choroid plexuses of the brain and causes central nervous symptoms.